Sicart Associates’s Oracle ORCL Stock Holding History

Sicart Associates’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,200	Closed	-$671K	–	114
2019 Q3	$671K	Buy	+12,200	New	+$674K	0.22%	57

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sicart Associates's ORCL Position: Q4 2019 in Review

Sicart Associates sold out of Oracle (ORCL) in Q4 2019, closing a stake of 12,200 shares — an estimated $671K sold.

Sicart Associates first reported a position in ORCL in Q3 2019 and held it in 1 quarter. The position peaked at $671K in Q3 2019. 1,917 funds tracked by Wall St. Rank hold ORCL as of Q4 2019.

Sicart Associates reported no remaining Oracle position as of Q4 2019 after selling out during the quarter.
Sicart Associates sold 12,200 Oracle shares in Q4 2019, an estimated $671K.
Sicart Associates first reported a position in Oracle in Q3 2019 and held it in 1 quarter.
Sicart Associates's Oracle position peaked at $671K in Q3 2019.
1,917 funds tracked by Wall St. Rank held Oracle as of Q4 2019.

Based on Sicart Associates's 13F filing for Q4 2019, filed 30 Jan 2020.